Obesity and Muscle Loss

The rise of GLP1 medications is transforming weight loss strategies, showing unprecedented effectiveness compared to previous interventions. While obesity rates may decline, an overlooked issue is the growing epidemic of under-muscled individuals, which poses serious health risks, particularly in relation to diabetes and cardiovascular diseases. The conversation hints at potential future changes in healthcare policies regarding these treatments.